Read More 2 minute read Funding News News Therapeutics GRO Biosciences Secures $60.3M in Series B Financing to Advance Protein Therapeutics Key Highlights GRO Biosciences raises $60.3M in Series B financing. Funds to advance lead program for refractory gout… byChris-Anne RoqueJuly 24, 2024
Read More 2 minute read Hiring News News GRObio Appoints Tracey Lodie, PhD, as Chief Development Officer Key Highlights Tracey Lodie, PhD, joins GRO Biosciences as Chief Development Officer, bringing over 20 years of experience in the biopharmaceutical industry.… byChris-Anne RoqueMarch 22, 2024